$0.6949
-0.02-2.88%
At close: -
$0.6951
0.000200.03%
After Hours: 8:44 AM EDT
Comments
Loading...
Xilio Therapeutics (NASDAQ:XLO) Stock, Earnings Estimates, EPS, And Revenue
Xilio Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 31
EPS Estimate
$-0.240
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$4.62M
Analyze the earnings history of Xilio Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Xilio Therapeutics (XLO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.22 | $-0.25 | 12.0 % |
| Q2 | 2024-08-08 | $-0.24 | $-0.23 | -4.35 % |
| Q1 | 2024-05-14 | $-0.59 | $-0.11 | -436.4 % |
| Q4 | 2024-04-01 | $-0.64 | $-0.74 | 13.5 % |
Xilio Therapeutics (XLO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $2.26M | $3.30M | -31.4 % |
| Q1 | 2024-05-14 | $0 | $30.00M | -100.0 % |
FAQ
When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?
Xilio Therapeutics (XLO) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Xilio Therapeutics (NASDAQ:XLO)?
The Actual EPS was $-0.22, which beat the estimate of $-0.25.
What were Xilio Therapeutics’s (NASDAQ:XLO) revenues?
The Actual Revenue was $2.3M, which missed the estimate of $3.3M.
Browse earnings estimates, EPS, and revenue on all stocks.